UBS Asset Management
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
UBS Asset Management delivers to the UK market the extensive capabilities of a truly global organisation.
Investor Profile
UBS Asset Management has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 22% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Private Equity, Series A rounds (top funding stages).
- Majority of deals are located in United States, China, France.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (22%)
- Private Equity (22%)
- Series A (22%)
- Post Ipo Equity (11%)
- Post Ipo Debt (11%)
- Series C (11%)
Country Focus
- United States (78%)
- China (11%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- France (11%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Life Science
- Medical
- Pharmaceutical
- Enterprise
- Manufacturing
- Business Intelligence
- E-commerce
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
